PubMed

The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

Srouji N.

Ann Intern Med. 2009 Feb 3;150(3):220; author reply 220. No abstract available. PMID: 19189917 [PubMed - indexed for MEDLINE]Related articlesFree article

The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

Gogol M.

Ann Intern Med. 2009 Feb 3;150(3):219; author reply 220. No abstract available. PMID: 19189914 [PubMed - indexed for MEDLINE]Related articlesFree article

The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

Dean NC.

Ann Intern Med. 2009 Feb 3;150(3):219; author reply 220. No abstract available. PMID: 19189915 [PubMed - indexed for MEDLINE]Related articlesFree article

Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure.

Wachter RM, Flanders SA, Fee C, Pronovost PJ.

Ann Intern Med. 2008 Jul 1;149(1):29-32.PMID: 18591635 [PubMed - indexed for MEDLINE]Related articlesFree article

Performance measurement in community-acquired pneumonia: consequences intended and unintended.

File TM Jr, Gross PA.

Clin Infect Dis. 2007 Apr 1;44(7):942-4. Epub 2007 Feb 20. No abstract available. PMID: 17342645 [PubMed - indexed for MEDLINE]Related articles

When to switch therapy in patients with severe community-acquired pneumonia.

Mortensen EM, Restrepo MI, Anzueto A.

Ann Intern Med. 2008 Apr 15;148(8):625; author reply 625-6. No abstract available. PMID: 18413627 [PubMed - indexed for MEDLINE]Related articlesFree article

Decisions about treating community-acquired pneumonia.

Mandell L.

Ann Intern Med. 2005 Feb 1;142(3):215-6. No abstract available. PMID: 15684211 [PubMed - indexed for MEDLINE]Related articlesFree article

Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.

Carratalà J, Fernández-Sabé N, Ortega L, Castellsagué X, Rosón B, Dorca J, Fernández-Agüera A, Verdaguer R, Martínez J, Manresa F, Gudiol F.

Ann Intern Med. 2005 Feb 1;142(3):165-72.PMID: 15684204 [PubMed - indexed for MEDLINE]Related articlesFree article

Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes?

Houck PM, Bratzler DW.

Curr Opin Infect Dis. 2005 Apr;18(2):151-6. Review.PMID: 15735420 [PubMed - indexed for MEDLINE]Related articles

[How far should we go in reducing the length of antibiotic therapy for community-acquired pneumonia?]

Mayaud C, Souidi A, Fartoukh M, Parrot A.

Rev Pneumol Clin. 2005 Apr;61(2):61-6. Review. French. No abstract available. PMID: 16012359 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Can patients with pneumonia take their antibiotics at home?

[No authors listed]

Ann Intern Med. 2005 Feb 1;142(3):I30. No abstract available. PMID: 15684200 [PubMed - indexed for MEDLINE]Related articlesFree article

Community-acquired pneumonia: is it time to shorten the antibiotic treatment?

Esposito S, Fiore M.

Expert Rev Anti Infect Ther. 2007 Dec;5(6):933-8. No abstract available. PMID: 18039078 [PubMed - indexed for MEDLINE]Related articles

What have we learned about how to measure quality of care for patients with community-acquired pneumonia?

Metersky ML, Abend SL, Meehan TP.

Respir Care Clin N Am. 2005 Mar;11(1):87-98. Review.PMID: 15763224 [PubMed - indexed for MEDLINE]Related articles

Reducing door-to-antibiotic time in community acquired pneumonia.

Hardy A, Whittaker P, Bastauros A, Srinivasan N, Elliott M.

Thorax. 2007 Oct;62(10):925. No abstract available. PMID: 17909196 [PubMed - indexed for MEDLINE]Related articles

Community-acquired pneumonia: treatment at home or in the hospital?

Aujesky D, Fine MJ.

Am J Med. 2008 Dec;121(12):1038-40. No abstract available. PMID: 19028194 [PubMed - indexed for MEDLINE]Related articles

Antimicrobial treatment of community-acquired pneumonia.

Restrepo MI, Anzueto A.

Clin Chest Med. 2005 Mar;26(1):65-73. Review.PMID: 15802167 [PubMed - indexed for MEDLINE]Related articles

Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come.

Cunha BA.

Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):78-81. Epub 2004 Jan 15. No abstract available. PMID: 14727150 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.

el Moussaoui R, de Borgie CA, van den Broek P, Hustinx WN, Bresser P, van den Berk GE, Poley JW, van den Berg B, Krouwels FH, Bonten MJ, Weenink C, Bossuyt PM, Speelman P, Opmeer BC, Prins JM.

BMJ. 2006 Jun 10;332(7554):1355.PMID: 16763247 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-course treatment of community-acquired pneumonia.

Mandell LA, File TM Jr.

Clin Infect Dis. 2003 Sep 15;37(6):761-3. Epub 2003 Aug 28. No abstract available. PMID: 12955635 [PubMed - indexed for MEDLINE]Related articles

Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization.

Battleman DS, Callahan M, Thaler HT.

Arch Intern Med. 2002 Mar 25;162(6):682-8.PMID: 11911722 [PubMed - indexed for MEDLINE]Related articlesFree article